Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank M Torti

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Critical Reviews in Oncogenesis|July 25, 2013
Cellular iron metabolism in prognosis and therapy of breast cancerSuzy V Torti, Frank M Torti
Current Opinion in Oncology|April 7, 2007
Bone metastases in prostate cancer: a targeted approachJonathan A Storey, Frank M Torti
The Biochemical Journal|June 20, 2002
Ferritin binds to light chain of human H-kininogen and inhibits kallikrein-mediated bradykinin releaseNarayanan Parthasarathy, Suzy V Torti, Frank M Torti
Advances in Experimental Medicine and Biology|July 2, 2025
Iron and CancerSuzy V Torti, Lia Tesfay, Frank M Torti
Current Medicinal Chemistry|April 8, 2003
The role of iron chelation in cancer therapyJoan L Buss, Frank M Torti, Suzy V Torti
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2006
Analytic considerations in economic evaluations of multinational cardiovascular clinical trialsFrank M Torti, Shelby D Reed, Kevin A Schulman
Biochemical Pharmacology|April 14, 2010
Ferritin H induction by histone deacetylase inhibitorsWei Wang, Xiumin Di, Suzy V Torti, et al.
The Prostate|May 31, 2012
Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1Bhavani Krishnan, Frank M Torti, Patricia E Gallagher, et al.
Oncotarget|November 16, 2017
Iron-responsive element-binding protein 2 plays an essential role in regulating prostate cancer cell growthZhiyong Deng, David H Manz, Suzy V Torti, et al.
Plos One|September 18, 2015
Cytoprotective Effect of Ferritin H in Renal Ischemia Reperfusion InjuryHeather C Hatcher, Lia Tesfay, Suzy V Torti, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Critical Reviews in Oncogenesis|July 25, 2013
Cellular iron metabolism in prognosis and therapy of breast cancerSuzy V Torti, Frank M Torti
Current Opinion in Oncology|April 7, 2007
Bone metastases in prostate cancer: a targeted approachJonathan A Storey, Frank M Torti
The Biochemical Journal|June 20, 2002
Ferritin binds to light chain of human H-kininogen and inhibits kallikrein-mediated bradykinin releaseNarayanan Parthasarathy, Suzy V Torti, Frank M Torti
Advances in Experimental Medicine and Biology|July 2, 2025
Iron and CancerSuzy V Torti, Lia Tesfay, Frank M Torti
Current Medicinal Chemistry|April 8, 2003
The role of iron chelation in cancer therapyJoan L Buss, Frank M Torti, Suzy V Torti
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2006
Analytic considerations in economic evaluations of multinational cardiovascular clinical trialsFrank M Torti, Shelby D Reed, Kevin A Schulman
Biochemical Pharmacology|April 14, 2010
Ferritin H induction by histone deacetylase inhibitorsWei Wang, Xiumin Di, Suzy V Torti, et al.
The Prostate|May 31, 2012
Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1Bhavani Krishnan, Frank M Torti, Patricia E Gallagher, et al.
Oncotarget|November 16, 2017
Iron-responsive element-binding protein 2 plays an essential role in regulating prostate cancer cell growthZhiyong Deng, David H Manz, Suzy V Torti, et al.
Plos One|September 18, 2015
Cytoprotective Effect of Ferritin H in Renal Ischemia Reperfusion InjuryHeather C Hatcher, Lia Tesfay, Suzy V Torti, et al.
Pageof 12